BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Çalışkan B, Demir Y, Türkeş C. Ophthalmic drugs: in vitro paraoxonase 1 inhibition and molecular docking studies. Biotechnol Appl Biochem 2022;69:2273-83. [PMID: 34786760 DOI: 10.1002/bab.2284] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Türkeş C, Demir Y, Biçer A, Cin GT, Gültekin MS, Beydemir Ş. Exploration of Some Bis‐Sulfide and Bis‐Sulfone Derivatives as Non‐Classical Aldose Reductase İnhibitors. ChemistrySelect 2023;8. [DOI: 10.1002/slct.202204350] [Reference Citation Analysis]
2 Yakan H, Muğlu H, Türkeş C, Demir Y, Erdoğan M, Çavuş MS, Beydemir Ş. A novel series of thiosemicarbazone hybrid scaffolds: Design, Synthesis, DFT studies, metabolic enzyme inhibition properties, and molecular docking calculations. Journal of Molecular Structure 2023. [DOI: 10.1016/j.molstruc.2023.135077] [Reference Citation Analysis]
3 Altıntop MD, Demir Y, Türkeş C, Öztürk RB, Cantürk Z, Beydemir Ş, Özdemir A. A new series of hydrazones as small-molecule aldose reductase inhibitors. Arch Pharm (Weinheim) 2023;:e2200570. [PMID: 36603162 DOI: 10.1002/ardp.202200570] [Reference Citation Analysis]
4 Demir Y, Türkeş C, Çavuş MS, Erdoğan M, Muğlu H, Yakan H, Beydemir Ş. Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif. Arch Pharm (Weinheim) 2022;:e2200554. [PMID: 36575148 DOI: 10.1002/ardp.202200554] [Reference Citation Analysis]
5 Yararli K, Ozer EB, Bayindir S, Caglayan C, Turkes C, Beydemir S. The synthesis, biological evaluation and in silico studies of asymmetric 3,5-diaryl-rhodanines as novel inhibitors of human carbonic anhydrase isoenzymes. Journal of Molecular Structure 2022. [DOI: 10.1016/j.molstruc.2022.134783] [Reference Citation Analysis]
6 Lolak N, Akocak S, Durgun M, Duran HE, Necip A, Türkeş C, Işık M, Beydemir Ş. Novel bis-ureido-substituted sulfaguanidines and sulfisoxazoles as carbonic anhydrase and acetylcholinesterase inhibitors. Mol Divers 2022. [PMID: 36136229 DOI: 10.1007/s11030-022-10527-0] [Reference Citation Analysis]
7 Demir Y, Tokalı FS, Kalay E, Türkeş C, Tokalı P, Aslan ON, Şendil K, Beydemir Ş. Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors. Mol Divers. [DOI: 10.1007/s11030-022-10526-1] [Reference Citation Analysis]
8 Korkmaz IN, Türkeş C, Demir Y, Öztekin A, Özdemir H, Beydemir Ş. Biological evaluation and in silico study of benzohydrazide derivatives as paraoxonase 1 inhibitors. J Biochem Mol Toxicol 2022;:e23180. [PMID: 35916346 DOI: 10.1002/jbt.23180] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Korkmaz IN, Türkeş C, Demir Y, Özdemir H, Beydemir Ş. Methyl benzoate derivatives: in vitro Paraoxonase 1 inhibition and in silico studies. J Biochem Mol Toxicol 2022;:e23152. [PMID: 35708184 DOI: 10.1002/jbt.23152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Güleç Ö, Türkeş C, Arslan M, Demir Y, Yeni Y, Hacımüftüoğlu A, Ereminsoy E, Küfrevioğlu Öİ, Beydemir Ş. Cytotoxic effect, enzyme inhibition, and in silico studies of some novel N-substituted sulfonyl amides incorporating 1,3,4-oxadiazol structural motif. Mol Divers 2022. [PMID: 35397086 DOI: 10.1007/s11030-022-10422-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]